UFP Technologies, Inc.

UFPT Healthcare Medical Devices

UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024. In the quarter to June 2026, revenue grew 15.1%, EPS grew 20.6%, free cash flow fell 35.8% and total debt fell 19.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

291.67 5.52 −1.86%
Market cap
$2.3B
P/E
31.2×
Fwd P/E
23.6×
Dividend yield
—
F-score
5/9
Altman Z
6.86
Beneish M
−2.57
Dividend safety
n/a

UFP Technologies, Inc. (UFPT) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, UFP Technologies, Inc. (UFPT) trades at a P/E ratio of 31.2×. Over the past ten years it has ranged from 11.7× (March 2020) to 55.3× (September 2024); the current reading is higher than 83% of that period. That is above the Medical Devices industry median of 23.2× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 25.0× (21.27%)
FY2024 31.8× 12.92%
FY2023 28.2× 34.48%
FY2022 20.9× (37.12%)
FY2021 33.3× 27.91%
FY2020 26.0× 39.59%
FY2019 18.7× 20.45%
FY2018 15.5× (29.18%)
FY2017 21.9× (5.75%)
FY2016 23.2× 4.21%

Quarterly newest first

Period P/E ratio Change
Jun 2026 28.3× 30.22%
Mar 2026 21.8× (13.10%)
Dec 2025 25.0× 9.36%
Sep 2025 22.9× (18.16%)
42 more quarters

Against its own ten years

Low 11.7× High 55.3×
Ten-year median 23.7×
Current reading's percentile 82

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on UFPT